proteolyt
enzym
play
essenti
metabol
regulatori
function
mani
biolog
process
also
offer
wide
rang
biotechnolog
applic
essenti
role
proteolyt
activ
need
tightli
regul
therefor
small
molecul
protein
inhibit
proteas
versatil
tool
field
medicin
agricultur
biotechnolog
medicin
proteas
inhibitor
use
diagnost
therapeut
agent
viral
bacteri
fungal
parasit
diseas
well
treat
cancer
immunolog
neurodegen
cardiovascular
diseas
involv
crop
protect
plant
pathogen
herbivor
pest
well
abiot
stress
drought
furthermor
proteas
inhibitor
indispens
protein
purif
procedur
prevent
undesir
proteolysi
heterolog
express
protein
extract
also
valuabl
tool
simpl
effect
purif
proteas
use
affin
chromatographi
larg
number
divers
proteas
prokaryot
yeast
filament
fungi
mushroom
expect
rich
sourc
proteas
inhibitor
well
applic
proteas
inhibitor
intim
connect
proteas
inhibit
prefac
proteas
inhibitor
overview
proteas
mode
regul
proteolyt
activ
provid
known
microbi
fungal
proteas
inhibitor
review
emphasi
protein
tabl
rather
smallmolecul
proteas
inhibitor
tabl
final
potenti
applic
field
medicin
crop
protect
biotechnolog
describ
base
target
proteas
microorgan
prokaryot
yeast
filament
fungi
higher
fungi
mushroom
select
review
sinc
proteas
inhibitor
microbi
origin
alreadi
proven
use
mani
differ
applic
higher
fungi
emerg
valuabl
sourc
new
proteas
inhibitor
uniqu
characterist
last
decad
therefor
offer
great
potenti
futur
applic
proteas
also
call
peptidas
proteolyt
enzym
constitut
larg
group
enzym
catalys
hydrolysi
peptid
bond
cleavag
peptid
bond
gener
lead
complet
degrad
protein
substrat
constitu
amino
acid
specif
lead
select
protein
cleavag
posttransl
modif
process
peptidas
cleav
peptid
bond
termini
polypeptid
chain
call
exopeptidas
endopeptidas
cleav
peptid
bond
within
polypeptid
chain
peptidas
classifi
accord
catalyt
type
aspart
cystein
glutam
serin
threonin
peptidas
accord
main
function
amino
acid
residu
activ
site
metallopeptidas
hand
whose
catalyt
activ
depend
presenc
dival
metal
ion
bound
within
activ
site
merop
databas
http
meropssangeracuk
peptidas
classifi
famili
accord
sequenc
similar
clan
accord
structur
similar
peptidas
famili
assign
merop
databas
releas
juli
clan
base
structur
data
barrett
rawl
et
al
peptidas
present
live
organ
includ
virus
bacteria
archaea
protist
fungi
plant
anim
serin
peptidas
form
abund
class
follow
metallo
cystein
aspart
threonin
peptidas
explos
growth
number
peptidas
famili
observ
eukaryot
organ
peptidas
bacteri
genom
half
mani
archaeal
genom
peptidas
gene
plant
mammal
genom
furthermor
strike
differ
composit
eubacteri
eukaryot
degradom
ie
complet
set
proteas
present
organ
sixteen
peptidas
famili
constitut
core
nearli
ubiquit
peptidas
famili
present
live
form
addit
peptidas
famili
wide
distribut
eukaryot
organ
anoth
ten
uniqu
higher
metazoan
organ
perform
mainli
limit
proteolysi
extracellular
environ
page
di
cera
rawl
et
al
addit
merop
databas
inform
proteas
found
sever
onlin
databas
includ
degradom
databas
http
degradomeuniovi
quesada
et
al
proteolysi
map
pmap
http
wwwproteolysisorg
compris
five
underlin
famili
includ
proteas
inhibitor
exclus
microbi
andor
fungal
origin
b
denot
number
sequenc
homologu
found
group
organ
less
armstrong
quigley
sottrupjensen
serin
proteas
inhibitor
ovomucoid
kazaltyp
chymotrypsin
subtilisin
famili
tightbind
laskowski
describ
stramenopil
oomycet
funguslik
microorgan
distantli
relat
fungi
eg
involv
pathogen
phytophtora
infestan
tian
et
al
rawl
barrett
aprotinin
chymotrypsin
famili
broad
inhibitori
specif
ascenzi
et
al
rawl
barrett
peptidas
b
inhibitor
subtilisin
famili
bacteri
inhibitor
propeptid
subtilisinlik
proteas
fungal
inhibitor
separ
polypeptid
eg
pleurotu
ostreatu
proteinas
inhibitor
yeast
proteinas
inhibitor
potent
unstabl
inhibitor
gradual
degrad
subtilisin
ascenzi
et
al
dohma
et
al
kojima
et
al
kojima
et
al
kojima
et
al
rawl
barrett
marinostatin
proteas
famili
subtilisin
certain
proteas
famili
chymotrypsin
tightbind
laskowski
structur
stabil
two
intern
ester
bond
essenti
inhibitori
activ
exclus
marin
bacteria
kanaori
et
al
rawl
barrett
ecotin
chymotrypsin
famili
tightbind
laskowski
primari
bind
site
activ
dimer
monom
bind
proteas
two
bind
site
ecotin
enterobacteria
parasit
perform
protect
role
host
digest
proteas
target
host
proteas
facilit
colon
structur
enabl
inhibit
multipl
proteas
chymotrypsin
fold
egger
et
al
eschenlau
et
al
rawl
barrett
streptomyc
subtilisin
inhibitor
ssi
famili
subtilisin
kexin
famili
trypsin
plasmin
metalloproteas
griselysin
famili
tightbind
laskowski
exclus
bacteri
actinomycetal
order
probabl
control
endogen
proteas
involv
proteolyt
activ
transglutaminas
kantyka
et
al
taguchi
et
al
tsuyuki
et
al
rawl
barrett
carboxypeptidas
inhibitor
serin
carboxypeptidas
famili
defens
role
predatori
insect
shown
regulatori
endogen
role
also
possibl
avanzo
et
al
odani
et
al
et
al
rawl
barrett
human
endogen
aspergillu
elastas
famili
unknown
homologu
found
ascomycet
speci
proteobacteria
none
character
biochem
okumura
et
al
okumura
et
al
rawl
barrett
serpin
chymotrypsin
subtilisin
famili
member
inhibit
also
cystein
proteas
papain
caspas
famili
trap
suicid
inhibitor
rapid
conform
chang
trap
cognat
proteas
coval
complex
physiolog
role
microbi
serpin
propos
protect
cellulosedegrad
apparatu
cellulosom
proteolyt
degrad
fungal
serpin
celpin
character
anaerob
fungu
piromyc
sp
kantyka
et
al
law
et
al
robert
et
al
steenbakk
et
al
cystein
proteas
inhibitor
thyropin
papainlik
proteas
famili
equistatin
inhibitor
unit
inhibit
aspart
proteas
cathepsin
famili
tightbind
present
anim
one
bacteri
pathogen
coxiella
burnetii
presum
acquir
gene
later
transfer
kantyka
et
al
rawl
barrett
survivin
caspasesaspartatespecif
cystein
proteas
famili
tightbind
sever
mechan
survivin
play
dual
role
mitot
regul
cell
divis
inhibitor
caspas
activ
process
apoptosi
fungal
homologu
identifi
ascomycet
basidiomycet
genom
fission
yeast
homologu
conserv
chromosom
passeng
protein
huang
et
al
luthring
et
al
rawl
chagasin
protozoan
mammalian
papainlik
cystein
proteas
famili
tightbind
parasit
chagasin
involv
regul
endogen
cystein
proteas
essenti
life
cycl
bacteria
archaea
chagasin
serv
endogen
regul
pathogen
speci
also
serv
protect
role
host
proteas
kantyka
et
al
santo
et
al
clitocypin
macrocypin
togeth
name
mycocypin
papainlik
cystein
proteas
famili
legumain
famili
serin
proteas
trypsin
famili
tightbind
mycocypin
small
except
stabl
protein
fold
form
core
sixstrand
support
loop
provid
versatil
surfac
inhibit
sever
type
proteas
uniqu
basidiomycet
probabl
endogen
regulatori
role
role
defenc
pathogen
infect
andor
predat
pest
defens
role
mycocypin
support
high
genet
variabl
conform
stabil
well
broad
inhibitori
profil
brzin
et
al
et
al
renko
et
al
et
al
et
al
et
al
high
specif
result
structur
stabil
inhibitor
complex
saccharopepsin
sinc
unstructur
inhibitor
solut
form
alpha
helix
upon
interact
enzym
activ
site
green
et
al
phylip
et
al
differ
databas
cutdb
pathwaydb
proteasedb
substratedb
profiledb
igarashi
et
al
occurr
proteas
live
organ
indic
critic
role
essenti
metabol
regulatori
function
mani
biolog
process
proteas
import
product
nutrient
growth
prolifer
extracellular
proteas
catalys
hydrolysi
protein
smaller
peptid
amino
acid
subsequ
absorpt
cell
constitut
import
step
nitrogen
metabol
proteas
perform
critic
regulatori
function
numer
physiolog
process
sinc
regul
fate
local
activ
mani
protein
modul
proteinprotein
interact
contribut
gener
transduct
amplif
molecular
signal
proteas
involv
wide
span
cellular
metabol
process
includ
regul
gene
express
dna
replic
transport
protein
cell
growth
differenti
cell
cycl
heat
shock
respons
so
respons
dna
damag
misfold
protein
respons
oxid
stress
respons
program
cell
death
lopezotin
bond
rao
et
al
furthermor
plant
proteas
import
buildup
breakdown
seed
storag
protein
seed
germin
protein
remobil
upon
organ
senesc
mani
development
process
embryogenesi
chloroplast
biogenesi
photomorphogenesi
hormon
signal
flower
develop
pollenpistil
interact
local
system
defenc
respons
pathogen
herbivor
simo
faro
sala
et
al
schaller
van
der
hoorn
moreov
anim
proteas
involv
tissu
morphogenesi
remodel
angiogenesi
neurogenesi
ovul
fertil
wound
repair
stem
cell
mobil
haemostasi
blood
coagul
inflamm
immun
autophagi
senesc
lopezotin
bond
proteas
microbi
fungal
origin
offer
wide
rang
biotechnolog
applic
alkalin
proteas
use
deterg
industri
year
proteas
elastolyt
keratinolyt
activ
use
leather
industri
dehair
bait
skin
hide
food
industri
use
proteas
chees
make
bake
prepar
variou
protein
hydrolys
meat
tender
manufactur
proteinrich
diet
pharmaceut
industri
proteas
found
use
therapeut
agent
well
addit
prepar
slowreleas
dosag
form
bioprocess
use
xray
film
silver
recoveri
involv
use
alkalin
proteas
proteas
allow
potenti
applic
manag
wast
variou
food
process
industri
household
activ
addit
industri
medic
applic
proteas
use
basic
research
exampl
proteas
select
peptid
bond
cleavag
use
protein
sequenc
unselect
proteinas
k
use
nucleic
acid
isol
trypsin
wide
use
maintain
anim
cell
cultur
kumar
takagi
rao
et
al
also
downsid
proteas
import
virul
factor
mani
pathogen
bacteria
parasit
virus
proteas
involv
acquir
nutrient
growth
prolifer
host
tissu
degrad
evas
host
immun
defenc
addit
colon
facilit
dissemin
function
also
involv
evad
host
immun
system
interrupt
cascad
pathway
disrupt
cytokin
network
excis
cell
surfac
receptor
inactiv
host
proteas
inhibitor
maeda
travi
potempa
supuran
et
al
proteas
play
essenti
role
life
death
process
live
organ
peptid
bond
hydrolysi
irrevers
anomali
proteolyt
activ
lead
numer
patholog
condit
includ
cancer
neurodegen
disord
inflammatori
cardiovascular
diseas
well
bacteri
viral
parasit
diseas
lopezotin
bond
turk
activ
proteas
regul
sever
level
includ
regul
gene
express
transcript
posttranscript
level
synthesi
inact
zymogen
blockad
endogen
inhibitori
protein
spatial
tempor
compartment
posttransl
modif
glycosyl
phosphoryl
cofactor
bind
proteolysi
degrad
lopezotin
bond
protein
proteas
inhibitor
constitut
import
mechan
regul
proteolyt
activ
classifi
approxim
accord
class
proteas
inhibit
exampl
serin
cystein
proteas
inhibitor
howev
compos
multipl
inhibitor
unit
paninhibitor
macroglobulin
famili
target
proteas
differ
catalyt
class
prevent
unambigu
classif
detail
classif
includ
merop
databas
http
meropssang
acuk
follow
hierarchi
similar
proteas
proteas
inhibitor
group
famili
base
sequenc
homolog
clan
base
protein
tertiari
structur
releas
juli
merop
databas
famili
proteas
inhibitor
avail
threedimension
structur
data
assign
differ
clan
rawl
famili
includ
member
microbi
fungal
origin
tabl
seven
famili
includ
member
exclus
bacteri
origin
five
famili
includ
member
exclus
fungal
origin
addit
protein
proteas
inhibitor
merop
databas
includ
list
smallmolecul
inhibitor
well
known
wide
use
mani
synthes
laboratori
howev
occur
natur
tabl
isol
bacteria
fungi
rawl
two
gener
mechan
proteas
inhibit
name
irrevers
trap
reaction
revers
tightbind
reaction
trap
reaction
work
endopeptidas
result
conform
chang
inhibitor
trigger
cleavag
intern
peptid
bond
host
proteas
fig
three
famili
util
trap
mechan
serpin
macroglobulin
viral
caspas
inhibitor
revers
tightbind
inhibit
widespread
best
known
standard
canon
laskowski
mechan
inhibitor
peptid
bond
cleav
peptidas
activ
site
substratelik
manner
inhibitor
slowli
releas
due
conform
stabil
stabil
loop
mimic
substrat
mechan
conclus
demonstr
inhibitor
serin
proteas
revers
tightbind
proteas
inhibitor
physic
block
proteas
activ
site
highaffin
bind
site
either
side
activ
site
fig
c
bind
inhibitor
activ
site
also
irrevers
electrophil
reactiv
group
inhibitor
form
coval
bond
amino
acid
residu
enzym
activ
site
also
inhibitor
block
exosit
substrat
bind
occur
addit
activ
site
proteas
christel
rawl
famili
protein
proteas
inhibitor
includ
member
microbi
fungal
origin
describ
tabl
inform
distribut
taxonom
group
given
tabl
proteas
inhibitor
describ
group
accord
catalyt
class
proteas
inhibit
follow
merop
inhibitor
classif
rawl
rawl
barrett
sinc
prokaryotederiv
proteas
inhibitor
review
recent
kantyka
et
al
inform
proteas
inhibitor
fungal
origin
includ
yeast
filament
fungi
mushroom
provid
among
smallmolecul
proteas
inhibitor
isol
bacteria
fungi
tabl
sever
show
broad
inhibitori
specif
inhibit
proteas
differ
catalyt
class
sever
inhibit
serin
cystein
proteas
antipain
chymostatin
leupeptin
serin
metalloproteas
bestatin
puromycin
metalloand
cystein
proteas
amastatin
metallo
cystein
serin
proteas
bacitracin
smallmolecul
cystein
proteas
inhibitor
best
known
ln
transepoxysuccinyl
leucyl
irrevers
inhibitor
origin
isol
aspergillu
japonicu
hanada
et
al
routin
use
classspecif
cystein
proteas
inhibitor
number
analogu
synthes
order
improv
select
particular
cystein
proteas
sever
inhibitor
specif
metalloproteas
inhibit
one
proteas
famili
eg
phosphoramidon
natur
smallmolecul
inhibitor
aspart
proteas
pepstatin
origin
isol
variou
speci
actinomycet
umezawa
et
al
inhibit
sever
famili
aspart
proteas
hexapeptid
contain
unusu
amino
acid
statin
rawl
proteas
play
import
part
almost
everi
biolog
process
therefor
unregul
activ
often
lead
diseas
review
excess
proteolysi
address
one
revers
proteas
inhibitor
excess
proteolysi
play
import
role
cancer
cardiovascular
inflammatori
neurodegen
bacteri
viral
parasit
diseas
due
obviou
relev
proteas
inhibitor
studi
extens
intent
develop
therapeut
drug
drag
salvesen
turk
haq
et
al
proteas
potenti
therapeut
target
review
accord
catalyt
type
group
diseasecaus
organ
human
diseas
inform
avail
proteas
inhibitor
proteas
describ
provid
emphasi
specif
inhibitor
yet
identifi
proteolyt
process
viru
polyprotein
structur
nonstructur
protein
essenti
part
viral
replic
cycl
make
proteas
import
antivir
drug
target
sever
viral
proteas
studi
therapeut
target
although
proteas
viru
could
potenti
antivir
target
virus
caus
chronic
diseas
eg
hiv
herp
viru
could
caus
largescal
epidem
eg
sar
coronaviru
dengu
viru
receiv
attent
sever
proteas
inhibitor
act
human
immunodefici
viru
proteas
homodimer
aspart
proteas
use
treat
infect
fig
exampl
proteas
inhibitor
util
irrevers
trap
reaction
revers
tightbind
reaction
b
c
proteas
shown
light
grey
activ
site
residu
black
inhibitor
dark
grey
serin
proteas
trypsin
complex
serpin
famili
pdb
id
proteas
cleav
reactiv
centr
loop
serpin
trigger
conform
chang
inhibitor
trap
proteas
inact
coval
complex
b
cystein
proteas
cathepsin
v
complex
clitocypin
famili
pdb
id
inhibitor
bind
proteas
activ
site
cleft
obstruct
access
substrat
c
aspart
proteas
plasmepsin
iv
complex
smallmolecul
inhibitor
pepstatin
pdb
id
inhibitor
bind
activ
site
proteas
low
molecular
weight
peptidomimet
inhibitor
whose
design
base
structur
compound
bind
proteas
activ
site
therapi
usual
use
combin
inhibitor
revers
transcriptas
abbenant
fairli
anderson
et
al
addit
number
design
synthet
inhibitor
potent
peptid
inhibitor
proteas
bacteri
origin
atbi
found
extremophil
bacillu
sp
dash
rao
vathipadiek
et
al
target
viral
proteas
belong
serin
catalyt
type
human
cytomegaloviru
hcmv
one
eight
human
herp
virus
widespread
popul
worldwid
infect
rate
caus
asymptomat
infect
healthi
individu
high
morbid
mortal
immunocompromis
individu
inhibitor
cytomegaloviru
proteas
describ
bacteri
streptomyc
fungal
cytonaema
origin
stoeva
efferth
anderson
et
al
addit
target
antivir
therapi
cytomegaloviru
proteasom
aim
hinder
recruit
host
protein
viru
replic
sever
synthet
natur
proteasom
inhibitor
eg
lactacystin
streptomyc
lactacystinaeu
known
report
obstruct
replic
sever
virus
includ
influenza
viru
herp
simplex
viru
type
paramyxoviru
rhabdovirus
well
cytomegaloviru
kaspari
bogner
serin
proteas
flavivirus
target
antivir
drug
develop
hepat
c
viru
dengu
viru
former
bloodtransmit
viru
caus
variou
liver
diseas
includ
cirrhosi
liver
cancer
latter
mosquitotransmit
diseas
caus
dengu
hemorrhag
fever
sever
structurebas
design
low
molecular
weight
inhibitor
differ
phase
clinic
evalu
anderson
et
al
lang
et
al
tomlinson
et
al
coronaviru
associ
sever
acut
respiratori
syndrom
sar
encod
chymotrypsinlik
cystein
proteas
pro
similar
picornaviru
proteas
sinc
sar
global
outbreak
sever
strategi
structurebas
design
low
molecular
weight
proteas
inhibitor
appli
search
antivir
drug
sar
anderson
et
al
siroi
et
al
first
consid
proteas
inhibitor
target
picornaviru
proteas
picornavirus
encod
proteas
import
human
anim
pathogen
polioviru
hepat
viru
coxsackieviru
human
rhinoviru
footandmouth
diseas
viru
inhibitor
target
proteas
human
rhinovirus
caus
common
cold
well
proteas
picornavirus
coronavirus
develop
base
structur
data
none
yet
success
pass
phase
clinic
evalu
neubauer
et
al
wang
liang
due
rapid
develop
resist
virus
search
novel
strategi
develop
inhibitor
target
differ
site
proteas
encourag
includ
search
novel
lead
compound
natur
sourc
structurebas
drug
develop
bacteri
pathogen
employ
array
virul
factor
enabl
colon
evas
host
defenc
dissemin
proteas
import
virul
factor
mani
pathogen
bacteria
play
role
acquir
nutrient
direct
degrad
host
tissu
compon
even
import
aim
disrupt
host
immun
respons
signal
cascad
review
potempa
pike
current
avail
antibiot
target
bacteri
cell
wall
synthesi
protein
synthesi
light
rapidli
spread
antibiot
resist
bacteri
proteas
promis
target
design
novel
antibiot
metalloproteas
abundantli
repres
primari
opportunist
pathogen
although
catalyt
class
found
proteas
often
associ
mobil
genet
element
plasmid
pathogen
island
integr
phage
express
constitut
regul
environment
cellular
signal
travi
potempa
wladyka
pustelni
omptin
outer
membran
protein
aspart
proteas
famili
found
sever
gramneg
bacteria
includ
pathogen
speci
escherichia
coli
ompt
yersinia
pesti
pla
shigella
flexneri
shigella
dysenteria
sopa
salmonella
enterica
pgte
legionella
pneumophila
lpa
plant
pathogen
agrobacterium
tumefacien
erwinia
pyrifolia
plaa
omptin
bacteri
virul
factor
addit
proteolyt
activ
possess
adhes
invas
activ
modul
coagul
system
sinc
act
plasminogen
activ
ompt
pla
pgte
lpa
inactiv
tissu
factor
pathway
inhibitor
ompt
pla
pgte
degrad
thrombinactivat
fibrinolysi
inhibitor
pla
pgte
degrad
complement
system
protein
pla
pgte
antimicrobi
peptid
ompt
pla
pgte
process
autotransport
ompt
sopa
lipopolysaccharid
lp
requir
enzymat
activ
omptin
uniqu
catalyt
mechan
combin
element
serin
aspart
proteas
partial
inhibit
serin
proteas
inhibitor
report
hritonenko
stathopoulo
vall
seron
et
al
yun
et
al
weak
substratebas
peptid
inhibitor
darg
shown
inhibit
ompt
dekker
et
al
colicin
immun
protein
shown
protect
colicin
degrad
ompt
escherichia
coli
duch
et
al
specif
inhibitor
report
specif
inhibitor
far
found
exfoli
toxin
glutamatespecif
serin
proteas
famili
produc
staphylococcu
aureu
caus
agent
staphylococc
scald
skin
syndrom
target
toxin
transmembran
glycoprotein
cadherin
superfamili
play
import
role
keratinocyt
cellcel
adhes
ladhani
immunoglobulin
proteas
proteas
serin
proteas
famili
produc
sever
pathogen
bacteria
includ
speci
caus
bacteri
mening
haemophilu
influenza
neisseria
meningitidi
streptococcu
pneumonia
proteas
enabl
colon
human
mucos
surfac
cleav
secretori
iga
antibodi
thu
disrupt
specif
immun
respons
except
earli
report
substrat
analogu
inhibitor
burton
et
al
small
synthet
peptid
inhibitor
bachovchin
et
al
neisseria
gonorrhoaea
proteas
develop
proteas
inhibitor
mistri
stockley
immunomodul
serin
proteas
peptidas
streptococci
famili
group
streptococcu
pyogen
scpa
group
b
streptococcu
agalacia
scpb
streptococci
describ
detail
streptococcu
pyogen
caus
agent
pharyng
also
caus
rheumat
fever
skin
infect
develop
sever
complic
includ
toxic
shock
syndrom
peptidas
import
streptococc
pathogenesi
specif
cleav
complement
therefor
prevent
recruit
phagocyt
cell
infect
site
cheng
et
al
collin
olsen
antibodi
rais
peptidas
use
inhibit
peptidas
vivo
park
cleari
peptidas
inhibitor
describ
serin
proteas
import
pathogenesi
factor
bacteria
involv
dental
diseas
treponema
denticola
spirochet
implic
progress
periodont
diseas
serin
proteas
trepolisin
also
call
dentilisin
famili
import
pathogenesi
factor
mediat
cytopath
effect
degrad
host
protein
includ
extracellular
matrix
compon
host
proteas
inhibitor
sela
broadrang
inhibitor
serin
proteas
famili
chymostatin
inhibit
trepolisin
howev
specif
inhibitor
describ
anoth
import
oral
caviti
pathogen
involv
periodont
diseas
porphyromona
gingivali
addit
cystein
proteas
discuss
follow
produc
serin
proteas
prolyl
tripeptidyl
peptidas
ptpa
famili
involv
degrad
host
connect
tissu
provid
nutrient
bacteri
growth
banbula
et
al
substratebas
specif
inhibitor
ptpa
develop
xu
et
al
bacteri
type
signal
peptidas
spase
famili
serin
proteas
widespread
among
gramneg
gramposit
bacteria
membran
proteas
requir
process
newli
synthes
secret
protein
addit
essenti
role
bacteri
viabil
import
antimicrobi
drug
target
involv
secret
mani
virul
factor
paetzel
et
al
synthet
penem
inhibitor
develop
inhibit
gramneg
escherichia
coli
gramposit
staphylococcu
aureu
staphylococcu
epidermidi
spase
variou
penem
deriv
display
differ
degre
activ
pathogen
bacteria
spase
allsop
et
al
harri
et
al
recent
substratebas
peptid
aldehyd
shown
promis
inhibitor
escherichia
coli
staphylococcu
aureu
spase
buzderlanto
et
al
howev
vitro
inhibitori
activ
vivo
antimicrobi
activ
inhibitor
correl
well
optim
search
novel
spase
inhibitor
expect
specif
inhibitor
describ
streptococc
pyrogen
exotoxin
b
speb
streptopain
cystein
proteas
famili
produc
strain
streptococcu
pyogen
multifunct
proteas
import
pathogenesi
factor
sever
immunomodul
activ
includ
releas
proinflammatori
molecul
degrad
extracellular
matrix
cleavag
igg
hing
region
degrad
immunoglobulin
addit
classspecif
cystein
proteas
inhibitor
peptid
deriv
shown
inhibit
speb
well
macroglobulin
snitrosyl
form
proteas
inhibitor
collin
olsen
ide
famili
anoth
cystein
proteas
streptococcu
pyogen
specif
cleav
igg
known
substrat
vincent
et
al
addit
specif
inhibitori
igg
antibodi
akesson
et
al
synthet
revers
inhibitor
design
aldehyd
compound
promis
howev
specif
data
yet
avail
inhibitor
berggren
et
al
staphylococcu
aureu
caus
rang
diseas
mild
skin
infect
lifethreaten
disord
includ
septicaemia
endocard
toxic
shock
syndrom
pneumonia
lowi
express
sever
extracellular
proteas
propos
role
pathogen
includ
serin
proteas
sspa
cystein
proteas
staphopain
b
scpa
sspb
metalloproteas
aureolysin
aur
shaw
et
al
staphopain
b
famili
papainlik
cystein
proteas
coexpress
respect
specif
inhibitor
staphostatin
b
dubin
role
pathogen
determin
staphopain
b
sspb
activ
glutamyl
peptidas
sspa
proteas
famili
express
operon
shaw
et
al
proteas
modul
surfac
protein
profil
influenc
bind
fibronectin
staphylococcu
aureu
mcgavin
et
al
sortas
cystein
proteas
famili
gramposit
bacteria
catalys
coval
attach
protein
cell
wall
peptidoglycan
shown
contribut
virul
sever
import
pathogen
includ
staphylococcu
aureu
bacillu
anthraci
listeria
monocytogen
streptococcu
pneumonia
therefor
consid
import
target
develop
novel
antiinfect
agent
sure
et
al
clanci
et
al
staphylococcu
aureu
sortas
srta
focu
sortas
inhibitor
develop
due
emerg
antibioticresist
strain
need
novel
antimicrobi
strategi
sever
type
srta
inhibitor
investig
includ
nonspecif
sulfhydryl
modifi
peptid
analogu
sort
signal
compound
plant
marin
organ
synthet
smallmolecul
inhibitor
sever
inhibitor
srta
describ
vari
strength
specif
howev
good
vitro
inhibitori
activ
yet
led
effect
vivo
sortas
inhibitor
maresso
schneewind
sure
et
al
clanci
et
al
cystein
proteas
clostripain
famili
secret
proteas
anaerob
bacterium
clostridium
histolyticum
caus
agent
ga
gangren
clostridi
myonecrosi
clostripain
select
hydrolys
arginyl
bond
constitut
import
clostridi
virul
factor
jozwiak
et
al
manab
et
al
addit
oxid
agent
thiolblock
agent
heavymet
ion
inhibit
clostripain
good
revers
inhibitor
describ
name
aziridin
peptid
ester
thu
promis
lead
compound
develop
specif
clostripain
inhibitor
schirmeist
peric
barrett
et
al
gingipain
extracellular
cystein
proteas
famili
produc
oral
pathogen
bacterium
porphyromona
gingivali
major
etiolog
bacterium
chronic
periodont
diseas
gingipain
compris
two
argininespecif
cystein
proteas
rgpa
rgpb
lysinespecif
cystein
proteas
kgp
constitut
major
virul
factor
periodontopathogen
bacterium
involv
multipl
facet
virul
surviv
includ
destruct
periodont
tissu
disrupt
host
immun
system
inactiv
host
proteinas
inhibitor
deregul
sever
proteinas
cascad
well
acquisit
nutrient
requir
bacteri
growth
surviv
periodont
pocket
fitzpatrick
et
al
travi
potempa
due
import
pathogenesi
consider
effort
put
discov
design
specif
inhibitor
gingipain
tetracyclin
inhibitor
prokaryot
protein
synthesi
shown
addit
antibiot
activ
inhibitori
activ
cystein
proteas
bind
proteinas
outsid
substrat
bind
site
imamura
et
al
peptidyl
chloromethan
use
specif
rgp
kgp
inhibitor
character
potempa
et
al
compound
shown
attenu
porphyromona
gingivali
virul
specif
kgp
inhibit
curti
et
al
base
histatin
cleavag
specif
small
peptid
analogu
design
specif
inhibit
rgp
kgp
respect
display
attenu
sever
virul
trait
porphyromona
gingivali
kadowaki
et
al
chlorhexidin
use
oral
healthcar
prepar
account
antimicrobi
effect
also
inhibit
proteolyt
activ
includ
gingipain
moreov
chlorhexidin
inhibitori
activ
rgingipain
enhanc
addit
zn
ii
also
use
human
oral
health
care
cronan
et
al
metalloproteas
import
virul
factor
mani
primari
opportunist
pathogen
bacteria
caus
major
infecti
diseas
cholera
salmonellosi
legionnair
diseas
cystic
fibrosi
botul
tetanu
anthrax
miyoshi
shinoda
either
direct
role
host
interact
indirect
role
process
import
virul
factor
therefor
much
invest
search
effect
proteas
inhibitor
use
treatment
jacobsen
et
al
none
yet
develop
would
use
clinic
metal
chelat
includ
edta
ethylenediaminetetraacet
acid
egta
ethylen
glycolbi
n
n
acid
inhibit
metalloproteas
gener
ubiquit
presenc
metalloproteas
prevent
use
broadspectrum
inhibitor
search
potent
specif
inhibitor
individu
metalloproteas
could
find
clinic
applic
import
studi
bacteri
metalloproteas
thermolysin
famili
includ
mpi
proteas
listeria
monocytogen
coccolysin
enterococcu
faecali
hemagglutininproteinas
vibrio
cholera
helicobyct
pylori
pseudolysin
pseudomona
aeruginosa
aureolysin
staphylococcu
aureu
legionella
pneumophila
proteas
clostridium
perfringen
inhibitor
thermolysin
famili
proteas
bacteri
origin
includ
isol
streptomyc
smallmolecul
inhibitor
phosphoramidon
protein
inhibitor
smpi
streptomyc
metalloproteinas
inhibitor
famili
anoth
famili
inhibitor
target
bacteri
thermolysin
famili
anim
origin
adekoya
sylt
supuran
et
al
rawl
barrett
bacteri
metalloproteas
light
chain
domain
zinc
metalloproteas
famili
tetanu
botulinum
neurotoxin
tent
bont
clostridium
tetani
clostridium
botulinum
respect
also
studi
extens
variou
consid
select
bont
tent
inhibitor
develop
strong
select
pseudotripeptid
inhibitor
bontb
blommaert
et
al
supuran
et
al
clostridium
histolyticum
collagenas
homologu
vibrio
famili
effect
connect
tissu
degrad
hydrolys
tripl
helic
region
collagen
physiolog
condit
target
therapi
diagnosi
clostridi
infect
sever
type
compound
found
inhibit
howev
addit
bacteri
collagenas
also
inhibit
vertebr
collagenas
supuran
et
al
barla
et
al
potent
select
inhibitor
yet
found
metalloproteas
famili
pathogen
bacteria
includ
serralysin
serratia
pseudomona
erwinia
aeruginolysin
pseudomona
aeruginosa
mirabilysin
proteu
mirabili
fragilysin
bacteroid
fragili
howev
inhibit
protein
inhibitor
bacteri
origin
belong
famili
hydroxam
inhibitor
includ
batimastat
supuran
et
al
rawl
barrett
anoth
group
medicin
import
bacteri
proteas
specif
inhibitor
yet
describ
compris
metalloexopeptidas
belong
sever
merop
famili
metallocarboxypeptidas
belong
famili
zinccontain
daladala
dipeptidas
vanx
famili
studi
view
abil
mediat
antibiot
resist
vancomycin
crowder
similarli
famili
membran
dipeptidas
includ
member
degrad
antibiot
carboxypeptidas
glutam
carboxypeptidas
famili
studi
view
clinic
use
treat
differ
type
cancer
holz
et
al
bacteri
metalloaminopeptidas
perform
essenti
cellular
function
protein
synthesi
mainten
studi
target
novel
antibiot
review
inhibitor
design
inhibit
bacteri
aminopeptidas
famili
eg
leucyl
aminopeptidas
lap
alanyl
aminopeptidas
methionin
aminopeptidas
cover
natur
design
compound
could
serv
lead
compound
inhibitor
aim
group
proteas
mucha
et
al
holz
et
al
supuran
et
al
rawl
barrett
bacteri
metalloproteas
cleav
immunoglobulin
iga
proteinas
famili
constitut
import
colon
factor
sever
pathogen
bacteria
eg
streptococcu
neisseria
haemophilu
clostridium
prevotella
capnocytophaga
bacteroid
strong
specif
inhibitor
avail
enzym
true
also
anoth
famili
pathogenesisrel
metalloproteas
famili
includ
staphylolysin
pseudomona
aeruginosa
lysostaphin
staphylococcu
simulan
addit
function
increas
virul
staphylolysin
lysostaphin
show
bactericid
activ
staphylococcu
aureu
studi
view
use
counter
drugresist
staphylococci
eg
methicillinand
vancomycinresist
staphylococcu
aureu
barequet
et
al
desboi
coot
metalloproteas
anthrax
lethal
factor
lf
famili
compon
anthrax
toxin
respons
major
symptom
death
associ
bacillu
anthraci
infect
kim
yoon
increas
interest
anthrax
vaccin
treatment
method
provok
use
bacillu
anthraci
spore
bioweapon
lethal
factor
lf
inhibitor
would
provid
twofold
protect
name
prevent
earli
spore
protect
macrophag
later
inhibit
lf
disrupt
signal
pathway
inactiv
mitogenactiv
protein
map
kinas
kinas
search
lf
inhibitor
use
combin
antibiot
treatment
aim
find
select
potent
lf
inhibitor
shoop
et
al
turk
would
non
cyto
toxic
good
biolog
stabil
bioavail
johnson
et
al
kim
et
al
li
et
al
predomin
fungal
diseas
afflict
immunocompromis
patient
caus
opportunist
pathogen
candida
sp
eg
candida
albican
candida
glabrata
candida
parapsilosi
aspergillu
sp
eg
aspergillu
fumigatu
aspergillu
niger
aspergillu
nidulan
aspergillu
calidoustu
follow
ascomycet
genu
fusarium
basidiomycet
genera
malassezia
cryptococcu
trichosporon
zygomycet
genera
rhizopu
mucor
boekhout
et
al
import
proteas
pathogen
opportunist
controversi
howev
aspart
serin
metalloendopeptidas
well
aminopeptidas
carboxypeptidas
dipeptidylpeptidas
secret
speci
propos
virul
factor
facilit
colon
invas
hydrolysi
host
protein
damag
cell
molecul
host
defenc
system
segal
yike
studi
secret
aspart
proteinas
candida
albican
sap
naglik
et
al
interestingli
proteas
inhibitor
target
viral
aspart
proteas
use
treat
hiv
infect
also
inhibit
candida
sap
reduc
occurr
candidiasi
patient
secret
aspart
proteas
thu
import
target
develop
new
proteas
inhibitor
base
compound
treat
candidiasi
bragasilva
santo
naglik
et
al
dash
et
al
fungal
proteas
also
import
fungal
allergen
belong
serin
catalyt
type
addit
proteas
inhibitor
aspergillu
fumigatu
aspergillu
niger
proteas
antigen
sensit
attenu
allerg
inflamm
hyperrespons
anim
model
yike
secret
alkalin
serin
proteas
aspergillu
fumigatu
shown
help
evad
host
immun
respons
degrad
human
complement
protein
therefor
good
target
drug
develop
behnsen
et
al
network
proteolyt
enzym
import
surviv
dermatophyt
microsporum
cani
trichophyton
rubrum
special
pathogen
fungi
infect
stratum
corneum
nail
hair
healthi
individu
includ
metalloendopeptidas
fungalysin
famili
serin
endopeptidas
subtilisin
famili
sever
exopeptidas
dipeptidyl
peptidas
famili
aminopeptidas
famili
carboxypeptidas
famili
monod
although
proteas
one
sever
group
virul
factor
pathogen
fungi
aid
invas
tissu
evas
immun
respons
therefor
specif
proteas
inhibitor
aim
would
constitut
valuabl
addit
present
use
antifung
drug
target
fungal
cell
wall
cell
membran
integr
dna
replicationand
mani
pathogen
strain
acquir
resist
mari
white
classspecif
broadspectrum
aspart
proteas
inhibitor
pepstatin
shown
inhibit
adhes
candida
albican
prevent
invas
mucos
tissu
damag
inhibit
sap
naglik
et
al
recent
shown
ergosterol
product
transcript
regul
activ
metalloproteas
essenti
surviv
cryptococcu
neoforman
presenc
antifung
drug
inhibit
sterol
biosynthesi
therefor
regul
ergosterol
pathway
includ
metalloproteas
constitut
promis
target
novel
antifung
therapeut
use
combin
sterol
synthesi
inhibitor
treat
cryptococcosi
immunocompromis
individu
bien
et
al
protozoan
parasit
diseas
includ
malaria
leishmaniasi
african
american
trypanosomiasi
import
infecti
diseas
world
high
mortal
morbid
rate
develop
countri
reason
persist
despit
prolong
use
antiparasit
drug
includ
toxic
side
effect
increas
emerg
drug
resist
therefor
research
past
year
focus
identifi
new
target
antiparasit
treatment
develop
substanc
suitabl
human
therapi
parasit
proteas
constitut
one
import
druggabl
target
sinc
key
virul
factor
due
essenti
role
cell
metabol
interact
host
zucca
savoia
renslo
mckerrow
mckerrow
et
al
aspart
proteas
plasmepsin
famili
import
haemoglobin
catabol
parasit
caus
malaria
plasmodium
falciparum
plasmodium
vivax
plasmodium
oval
plasmodium
malaria
target
design
novel
antimalari
drug
ie
select
proteas
inhibitor
although
plasmepsin
inhibitor
includ
broadspectrum
pepstatin
shown
antimalari
effect
main
challeng
still
remain
design
inhibitor
would
activ
differ
plasmepsin
ii
iv
histoaspart
proteas
hap
involv
haemoglobin
degrad
also
inact
homolog
human
aspart
proteas
cathepsin
e
zucca
savoia
rosenth
ersmark
et
al
gil
et
al
addit
plasmepsin
cystein
proteas
falcipain
famili
metalloproteas
falcilysin
famili
aminopeptidas
target
develop
new
antimalari
proteas
inhibitor
synergist
effect
observ
combin
use
eg
cocktail
aspart
cystein
proteas
inhibitor
mckerrow
et
al
rosenth
zucca
savoia
trenholm
et
al
cystein
proteas
similar
falcipain
famili
associ
pathogenesi
trypanosomiasescruzipain
trypanosoma
cruzi
chaga
diseas
brucipain
rhodesain
trypanosoma
brucei
sleep
sick
cruzipain
cruzain
extens
studi
consid
promis
target
chemotherapi
sinc
critic
parasit
viabil
stage
infect
especi
nutrit
acquisit
tissu
invas
host
immun
respons
evas
duschak
couto
irrevers
inhibitor
effect
preclin
model
chaga
diseas
howev
safer
treatment
would
achiev
util
revers
highli
specif
cruzipain
inhibitor
beaulieu
et
al
mckerrow
et
al
brak
et
al
cystein
proteas
implic
pathogenesi
leishmania
speci
major
virul
factor
substanti
modifi
immun
respons
surfac
metalloproteas
leishmanolysin
famili
shown
essenti
establish
maintain
infect
would
make
promis
target
develop
select
proteas
inhibitor
antiparasit
chemotherapi
olivi
hassani
yao
addit
comput
design
develop
optim
suitabl
proteas
inhibitor
base
structur
target
proteas
search
novel
type
inhibitor
natur
sourc
pereira
et
al
fungi
microb
import
identifi
new
lead
compound
serin
proteas
also
neglect
group
potenti
target
protozoan
proteas
involv
pathogen
although
sever
subtilisin
famili
describ
plasmodium
falciparum
toxoplasma
gondii
two
oligopeptidas
famili
trypanosoma
cruzi
mckerrow
et
al
addit
protozoan
parasit
helminth
includ
parasit
roundworm
nematod
flatworm
trematod
cestod
also
caus
import
parasit
infect
cystein
cathepsin
famili
import
mani
aspect
helminthhost
relationship
potenti
target
develop
antihelminth
drug
cystein
proteas
inhibitor
shown
impair
fecund
liver
fluke
fasciola
hepatica
blood
fluke
schistosoma
mansoni
anim
model
howev
similar
host
cathepsin
togeth
import
call
design
specif
select
proteas
inhibitor
altern
drug
design
could
exploit
bioavail
pharmacokinet
dynam
properti
target
parasit
proteas
preferenti
robinson
et
al
addit
proteas
parasitederiv
proteas
inhibitor
play
import
role
manipul
host
immun
system
establish
nich
success
feed
reproduct
helminth
parasit
therefor
proteas
inhibitor
also
import
target
immunolog
control
helminth
parasit
infect
make
proteas
insensit
parasitederiv
proteas
inhibitor
valuabl
candid
new
type
antihelminth
therapi
knox
stepek
et
al
abil
tumour
cell
invad
extracellular
barrier
metastas
distant
site
associ
activ
proteas
ko
lah
major
molecular
mechan
involv
activ
role
variou
intraand
extracellular
proteas
dissolut
remodel
connect
tissu
basement
membran
includ
matrix
metalloproteas
mmp
serin
proteinas
urokinas
tissu
type
plasminogen
activ
upa
tpa
plasmin
aspart
proteinas
cathepsin
cystein
proteinas
cathepsin
b
h
l
schmitt
et
al
addit
extracellular
matrix
remodel
proteas
regul
sever
process
lead
progress
malign
diseas
cell
adhes
migrat
differenti
prolifer
signal
tumour
cell
well
accept
tumourassoci
proteolyt
activ
escap
control
endogen
proteas
inhibitor
treatment
patient
exogen
proteas
inhibitor
may
suppress
progress
diseas
improv
outcom
cancer
patient
howev
treatment
specif
target
tumourassoci
proteas
caus
harm
action
involv
numer
physiolog
process
cell
tissu
sever
proteas
inhibitor
fail
clinic
trial
due
lack
specif
result
sever
side
effect
andor
lack
clinic
benefit
treat
patient
turk
coussen
et
al
new
approach
develop
proteas
inhibitor
applic
therapeut
intervent
includ
structurebas
medicin
chemistri
develop
molecular
system
deliv
inhibitor
site
action
among
smallmolecul
inhibitor
bacteri
fungal
origin
peptidyl
aldehyd
leupeptin
antipain
hexapeptid
pepstatin
epoxysuccinyl
peptid
analogu
studi
anticanc
agent
thiolproteas
specif
inhibitor
origin
isol
aspergillu
japonicu
hanada
et
al
studi
extens
potenti
antitumour
agent
cell
cultur
anim
model
deriv
display
select
differ
cystein
proteas
frlan
gobec
repres
next
step
toward
applic
treat
cancer
diseas
design
basi
xray
crystal
structur
individu
cathepsin
studi
cathepsin
b
specif
inhibitor
cathepsin
l
specif
inhibitor
cathepsin
x
specif
inhibitor
cathepsin
specif
inhibitor
design
basi
structur
leupeptin
antipain
katunuma
antitumour
activ
exhibit
particularli
specif
inhibitor
cystein
proteas
cathepsin
b
johansson
et
al
appear
crucial
tumour
cell
invas
lah
et
al
anim
model
shown
reduc
tumour
growth
invas
angiogenesi
mani
cancer
type
includ
pancreat
cancer
melanoma
breast
tumour
test
anim
model
cell
permeabl
epoxysuccinyl
inhibitor
improv
esterif
ester
less
activ
free
acid
howev
cell
rapidli
hydrolys
activ
form
better
cell
permeabl
demonstr
ethyl
ester
methyl
ester
also
highli
solubl
effect
prolong
period
frlan
gobec
metalloproteas
import
group
proteas
consid
extens
target
cancer
therapi
due
mani
role
play
carcinogenesi
tumour
invas
growth
dispers
howev
divers
endogen
metalloproteas
numer
versatil
physiolog
role
prevent
use
broadspectrum
metalloproteas
inhibitor
much
effort
invest
determin
metalloproteas
target
design
highli
select
potent
proteas
inhibitor
base
structur
characterist
individu
target
metalloproteas
coussen
et
al
biala
kafarski
dorman
et
al
overal
kleifeld
sever
proteas
serin
catalyt
type
also
target
design
specif
proteas
inhibitor
use
cancer
treatment
includ
urokinas
plasminogen
activ
matriptas
abbenant
fairli
biala
kafarski
uliss
et
al
broadrang
microbi
inhibitor
serin
cystein
threonin
proteas
leupeptin
antipain
also
shown
inhibit
malign
transform
vaccari
et
al
tumourigenesi
hozumi
et
al
threonin
catalyt
type
proteolysi
present
proteasom
sever
chemic
class
natur
synthet
proteasom
inhibitor
consid
anticanc
agent
preferenti
antiprolif
proapoptot
activ
cancer
cell
kisselev
goldberg
abbenant
fairli
biala
kafarski
cecarini
et
al
chen
et
al
aspart
proteas
inhibitor
pepstatin
also
frequent
test
antitumour
agent
sinc
cathepsin
identifi
import
tumour
promot
factor
greenbaum
sutherland
bene
et
al
irregular
function
proteas
associ
varieti
diseas
repres
target
therapeut
applic
catalyt
type
proteas
inhibitor
smallmolecul
inhibitor
bacteri
fungal
origin
describ
alreadi
previou
section
particularli
epoxysuccinyl
inhibitor
report
potenti
protect
agent
autoimmun
neurodegen
antiinflammatori
cardiovascular
diseas
osteoporosi
muscular
dystrophi
diabet
other
demonstr
caus
switch
cell
respons
due
differ
role
cystein
cathepsin
b
l
antigen
process
present
katunuma
cathepsin
inhibitor
shown
suppress
sj
gren
syndrom
autoimmun
diseas
associ
process
cathepsin
saegusa
et
al
cathepsin
x
inhibitor
reduc
activ
integrin
receptor
lymphocyt
functionassoci
antigen
molecul
involv
cell
adhes
prolifer
migrat
jevnikar
et
al
overexpress
activ
cathepsin
x
typic
autoimmun
diseas
particularli
psoriasi
inhibitor
significantli
enhanc
prolifer
neuron
cell
neuritogenesi
prevent
process
neurotroph
factor
cathepsin
x
obermaj
et
al
epoxysuccinyl
inhibitor
test
sever
anim
model
neurodegen
diseas
shown
restor
normal
synapt
function
mous
model
alzheim
diseas
overexpress
amyloid
precursor
protein
app
presenilin
trinches
et
al
also
reduc
accumul
neurotox
betaamyloid
peptid
brain
presum
inhibit
cathepsin
b
involv
process
amyloid
precursor
protein
hook
et
al
aspart
proteas
also
known
belong
merop
famili
compos
two
presenilin
belong
merop
famili
import
therapeut
target
treat
alzheim
diseas
sever
compound
design
reduc
activ
clinic
trial
de
strooper
et
al
anoth
import
target
aspart
proteas
renin
famili
part
complex
reninangiotensinaldosteron
system
regul
blood
pressur
electrolyt
balanc
sever
inhibitor
design
base
renin
structur
activ
one
aliskiren
first
nonpeptid
oral
administ
direct
renin
inhibitor
avail
market
manag
hypertens
nguyen
et
al
barrio
escobar
first
proteas
inhibitor
use
human
therapeut
agent
name
inhibitor
metalloproteas
angiotensinconvert
enzym
ace
also
hypertens
relat
import
regul
reninangiotensin
system
ace
inhibitor
use
treat
hypertens
also
implic
cardiovascular
renal
diseas
abbenant
fairli
ondetti
et
al
inhibitor
collagenolyt
enzym
cathepsin
l
k
prevent
bone
remodel
use
treatment
osteoporosi
sever
synthet
cathepsin
k
inhibitor
differ
stage
clinic
trial
addit
osteoporosi
also
consid
applic
arthriti
atherosclerosi
obes
cancer
bromm
lecail
administr
cathepsin
l
inhibitor
significantli
reduc
invas
metastasi
format
bone
katunuma
methyl
ester
test
treat
muscular
dystrophi
howev
develop
stop
phase
iii
due
insuffici
effect
hepat
injuri
rat
fukushima
et
al
antipain
leupeptin
pepstatin
also
test
treatment
muscular
dystrophi
howev
persuas
benefit
demonstr
anim
model
specif
inhibitor
design
target
serin
aminopeptidas
dipeptidyl
peptidas
iv
clinic
trial
manag
type
diabet
abbenant
fairli
tahrani
et
al
endogen
plant
proteas
inhibitor
constitut
one
plant
defenc
strategi
pathogen
parasit
herbivor
organ
target
import
proteolyt
virul
factor
phytopathogen
bacteria
fungi
parasit
virus
prevent
role
nutrient
acquisit
evas
host
defenc
furthermor
target
digest
proteas
herbivor
pest
eg
insect
mite
slug
prevent
util
foodderiv
organ
nitrogen
growth
develop
ryan
haq
et
al
sinc
pest
pathogen
depend
util
proteas
strong
select
pressur
oper
develop
resist
plant
endogen
defens
proteas
inhibitor
haq
et
al
jongsma
beekwild
therefor
search
novel
proteas
inhibitor
potenti
protect
function
import
develop
environment
friendli
pest
pathogen
manag
strategi
addit
investig
aim
augment
crop
endogen
resist
convent
breed
sever
proteas
inhibitor
plant
origin
use
prepar
genet
modifi
crop
plant
superior
abil
biotic
stress
resist
ferri
gatehous
use
proteas
inhibitor
insect
pest
manag
gain
attent
insect
pest
caus
major
econom
loss
annual
lepidopteran
butterfli
moth
larva
consid
destruct
agricultur
pest
caus
signific
econom
impact
also
belong
order
coleoptera
beetl
diptera
true
fli
hemiptera
eg
aphid
orthoptera
eg
locust
thysanoptera
thrip
caus
either
direct
damag
crop
feed
indirect
damag
transmit
viral
diseas
secondari
microbi
infect
notabl
destruct
capac
migratori
locust
locusta
migratoria
sever
beetl
includ
colorado
potato
beetl
leptinotarsa
decemlineata
boll
weevil
anthonomu
grandi
japanes
beetl
popillia
japonica
western
corn
rootworm
diabrotica
virgifera
virgifera
mani
speci
aphid
belong
famili
superfamili
aphidoidea
differ
catalyt
type
proteas
provid
predomin
proteolyt
activ
differ
group
insect
pest
serin
proteas
predomin
digest
proteolysi
insect
speci
eg
lepidoptera
diptera
cystein
proteas
predomin
hemiptera
coleoptera
thysanoptera
addit
aspart
metalloproteas
complement
protein
digest
differ
degre
insect
order
terra
ferreira
therefor
proteas
inhibitor
target
differ
group
proteas
shown
variabl
antinutrit
effect
fed
differ
insect
pest
catalyt
classspecif
smallmolecul
proteas
inhibitor
microbi
origin
often
use
proofofprincipl
feed
experi
protein
proteas
inhibitor
employ
gener
insectresist
transgen
plant
predominantli
plant
origin
except
animalderiv
proteas
inhibitor
gene
haq
et
al
dunaevski
et
al
malon
et
al
import
protein
use
construct
pestresist
transgen
crop
insecticid
protein
deriv
bacillu
thuringiensi
bt
genet
modifi
maiz
cotton
varieti
express
bt
toxin
becom
import
compon
agricultur
worldwid
reduc
use
pesticid
lower
product
cost
ferri
gatehous
kumar
et
al
involv
endogen
proteas
inhibitor
natur
plant
resist
herbivor
probabl
basi
adapt
lepidopteran
coleopteran
speci
ingest
proteas
inhibitor
observ
sever
speci
jongsma
beekwild
wu
et
al
bonadebottino
et
al
lara
et
al
circumv
antinutrit
effect
ingest
proteas
inhibitor
either
overexpress
nativ
gut
proteas
product
insensit
proteas
degrad
ingest
proteas
inhibitor
ferri
gatehous
jongsma
beekwild
therefor
pyramid
stack
differ
famili
inhibitor
increas
spectrum
inhibitori
activ
shown
synergist
effect
well
combin
proteas
inhibitor
gene
gene
insecticid
protein
name
lectin
bt
bacteri
toxin
inhibitor
ferri
gatehous
schluter
et
al
christou
et
al
malon
et
al
furthermor
use
proteas
inhibitor
microbi
fungal
origin
could
offer
superior
characterist
stabil
resist
proteolyt
degrad
divers
inhibitori
pattern
potent
antinutrit
insecticid
effect
exampl
util
microbi
smallmolecul
inhibitor
antinutrit
agent
avail
eg
aminopeptidas
inhibitor
actinomycet
amastatin
bestatin
red
flour
beetl
tribolium
castaneum
oppert
et
al
aspart
proteas
inhibitor
pepstatin
actinomycet
cowpea
bruchid
callosobruchu
maculatu
amirhusin
et
al
serin
cystein
proteas
inhibitor
leupeptin
actinomycet
western
corn
rootworm
diabrotica
virgifera
kim
mullin
cystein
proteas
inhibitor
aspergillu
japonicu
colorado
potato
beetl
leptinotarsa
decemlineata
bolter
latoszekgreen
use
protein
proteas
inhibitor
advantag
sinc
transgen
plant
express
pest
resist
gene
control
manner
repres
stabl
cheap
propag
sourc
would
lower
amount
pesticid
need
make
plant
protect
environ
friendli
knowledg
exampl
protein
proteas
inhibitor
microbi
fungal
origin
effect
antinutrit
agent
cystein
proteas
inhibitor
macrocypin
famili
edibl
parasol
mushroom
macrolepiota
procera
shown
detriment
growth
develop
colorado
potato
beetl
larva
et
al
high
capac
develop
resist
insecticid
protein
major
insect
pest
drive
search
effect
proteas
inhibitor
novel
protein
proteas
inhibitor
aim
serin
proteas
would
use
manag
major
agricultur
pest
beet
armyworm
spodoptera
exigua
cotton
bollworm
helicoverpa
armigera
helicoverpa
zea
tobacco
hornworm
manduca
sexta
combin
serin
cystein
proteas
inhibitor
would
use
eg
boll
weevil
anthonomu
grandi
cowpea
weevil
callosobruchu
maculatu
red
flour
beetl
tribolium
castaneum
cystein
proteas
inhibitor
would
exampl
use
colorado
potato
beetl
leptinotarsa
decemlineata
western
corn
rootworm
diabrotica
virgifera
banana
weevil
cosmopolit
sordidu
pea
aphid
acyrtosiphon
pisum
microorgan
gener
recogn
safe
edibl
mushroom
offer
valuabl
sourc
novel
proteas
inhibitor
would
also
accept
use
crop
human
consumpt
addit
insect
pest
herbivor
caus
signific
crop
loss
worldwid
includ
mite
slug
case
cystein
proteas
constitut
predomin
digest
proteolyt
activ
plant
cystatin
shown
detriment
mite
develop
reproduct
perform
feed
trial
one
major
mite
pest
agricultur
crop
twospot
spider
mite
tetranychu
urtica
acari
tetranychida
carrillo
et
al
similarli
growth
juvenil
slug
derocera
reticulatum
import
agricultur
horticultur
pest
significantli
reduc
fed
leaf
tissu
overexpress
plant
cystein
proteas
inhibitor
walker
et
al
therefor
proteas
inhibitor
microbi
fungal
origin
great
potenti
protect
plant
import
mite
pest
suppress
growth
rate
slug
popul
addit
antinutrit
characterist
differ
insect
pest
anoth
advantag
applic
proteas
inhibitor
crop
protect
addit
protect
herbivor
pest
offer
cumul
protect
nematod
bacteri
fungal
viral
pathogen
haq
et
al
use
proteas
inhibitor
one
mani
strategi
protect
plant
parasit
nematod
target
intestin
proteas
mostli
cystein
catalyt
class
therefor
heterolog
express
plant
cystein
proteas
inhibitorsphytocystatin
famili
effect
differ
degre
beetcyst
nematod
heterodera
schachtii
rootknot
nematod
meloidogyn
incognita
potato
cyst
nematod
globodera
pallida
burrow
nematod
radopholu
simili
mccarter
haq
et
al
plantderiv
serin
proteas
inhibitor
offer
satisfactori
nematod
resist
transgen
wheat
cereal
cyst
nematod
heterodera
avena
vishnudasan
et
al
mccarter
antifung
effect
serin
proteas
inhibitor
determin
plantderiv
proteas
inhibitor
target
secret
proteas
mainli
famili
phytopathogen
fungi
involv
plant
cell
wall
penetr
hypha
wong
et
al
addit
aspart
cystein
proteas
also
fairli
widespread
valueva
mosolov
repres
potenti
target
protect
proteas
inhibitor
similarli
phytopathogen
bacteria
secret
proteas
involv
pathogenesi
mainli
aid
plant
cell
wall
degrad
togeth
pectinas
cellulas
hemicellulas
contribut
massiv
degener
plant
tissu
exampl
wilt
eg
ralstonia
solanacearum
softrot
diseas
eg
erwinia
chrysanthemi
erwinia
carotovora
kunkel
chen
cystein
proteas
belong
famili
implic
pathogen
mani
phytopathogen
belong
genera
pseudomona
xantomona
ralstonia
erwinia
pantoea
effector
type
iii
secret
system
constitut
potenti
target
protect
proteas
inhibitor
kunkel
chen
mosolov
valueva
import
polyprotein
process
replic
virus
especi
famili
potyvirida
comovirida
indic
proteas
inhibitor
could
mediat
resist
plant
virus
inhibit
target
viral
proteas
inde
rice
cystatin
oryzacystatin
express
tobacco
plant
confer
resist
potato
viru
pvi
tobacco
etch
viru
tev
correl
increas
inhibit
target
papainlik
proteas
sudarshana
et
al
addit
protect
role
biotic
stress
endogen
plant
proteas
inhibitor
implic
control
proteolyt
system
plant
abiot
stress
dehydr
compon
drought
increas
salt
concentr
freez
vaseva
et
al
shown
chang
metabol
trigger
water
deficit
involv
activ
involv
regul
proteolysi
assist
protect
protein
dehydrin
chaperon
cellular
respons
increas
level
denatur
aggreg
oxid
damag
protein
accumul
dehydr
stress
brzin
benchaban
et
al
bray
hoekstra
et
al
feller
overexpress
endogen
proteas
inhibitor
increas
resist
drought
stress
shown
overexpress
cystein
proteas
inhibitor
cystatin
model
plant
arabidopsi
thaliana
overexpress
serin
proteas
inhibitor
oryza
sativa
chymotrypsin
inhibitor
rice
latter
show
improv
drought
resist
term
yield
loss
field
huang
et
al
although
proteas
inhibitor
great
potenti
protect
crop
abiot
stress
condit
detail
knowledg
specif
role
differ
proteas
respons
abiot
stress
need
exogen
proteas
inhibitor
use
manipul
improv
drought
resist
plant
vaseva
et
al
smallmolecul
proteas
inhibitor
routin
use
buffer
addit
prepar
protein
extract
order
prevent
proteolyt
degrad
protein
purif
procedur
broadspectrum
inhibitor
cover
differ
catalyt
class
gener
use
includ
pepstatin
aspart
proteas
cystein
proteas
chymostatin
serin
proteas
antipain
cystein
serin
proteas
leupeptin
cystein
serin
threonin
proteas
origin
isol
actinomycet
inhibit
serin
proteas
synthet
proteas
inhibitor
aebsf
pefabloc
benzenesulfonyl
fluorid
hydrochlorid
physiolog
stabl
deriv
pmsf
phenylmethanesulfonyl
fluorid
use
chelat
agent
edta
gener
use
inhibit
metalloproteas
certain
applic
inhibitor
actinomycet
originphosphoramidon
metallopeptidas
inhibit
bestatin
aminopeptidas
inhibit
unwant
proteolyt
degrad
caus
sever
reduct
yield
heterolog
express
protein
variou
express
system
therefor
natur
engin
proteasedefici
strain
often
use
host
bacteri
eg
escherichia
coli
yeast
eg
pichia
pastori
smd
filament
fungal
eg
aspergillu
niger
prt
pep
express
system
howev
strain
may
exhibit
optim
bioprocess
characterist
due
lower
fit
trait
altern
strategi
therefor
use
prevent
proteolyt
degrad
recombin
protein
includ
modif
recombin
protein
sequenc
remov
proteas
cleavag
site
without
affect
protein
function
express
stabil
fusion
partner
optim
cultiv
condit
ph
temperatur
medium
composit
bioprocess
strategi
use
proteas
inhibitor
secret
recombin
protein
smallmolecul
inhibitor
ad
cultur
medium
inhibit
predomin
secret
proteolyt
activ
host
organ
often
serin
aspart
catalyt
type
anoth
strategi
coexpress
appropri
protein
proteas
inhibitor
recombin
protein
may
howev
influenc
yield
complic
downstream
purif
procedur
potvin
et
al
sharma
et
al
rozkov
enfor
addit
protect
proteolyt
degrad
recombin
protein
express
process
proteas
inhibitor
fusion
partner
advantag
one
exampl
use
bacteri
periplasm
serin
proteas
inhibitor
ecotin
famili
vehicl
secret
periplasm
space
escherichia
coli
paal
et
al
anoth
exampl
serin
proteas
inhibitor
oyster
mushroom
pleurotu
ostreatu
proteinas
inhibitor
famili
serv
intramolecular
chaperon
enabl
proper
refold
fuse
subtilisin
proteas
inclus
bodi
express
heterolog
bacteri
express
system
kojima
et
al
strategi
use
coexpress
protein
proteas
inhibitor
reduc
proteolyt
degrad
heterolog
express
protein
success
implement
plant
express
system
prepar
proteasedefici
host
case
applic
essenti
role
proteas
growth
develop
plant
express
system
offer
mani
advantag
bacteri
yeast
express
system
eg
posttransl
modif
capabl
anim
cell
line
eg
lower
cost
contamin
risk
largescal
recombin
protein
product
yet
commerci
due
low
level
protein
express
heterolog
protein
accumul
latter
influenc
target
express
specif
organel
eg
endoplasm
reticulum
tissu
eg
seed
tuber
coexpress
stabil
fusion
partner
proteas
inhibitor
coexpress
protect
proteas
inhibitor
advers
effect
plant
growth
develop
describ
previous
exampl
proteas
inhibitor
express
insectresist
transgen
plant
furthermor
heterolog
express
proteas
inhibitor
offer
ad
advantag
protect
proteolysi
also
ex
planta
especi
earli
step
purif
crude
protein
extract
thu
minim
need
addit
proteas
inhibitor
extract
buffer
rivard
et
al
desai
et
al
doran
benchaban
et
al
far
proteas
inhibitor
plant
anim
origin
use
coexpress
partner
use
microbi
fungal
proteas
inhibitor
could
offer
superior
protect
characterist
howev
properti
protein
interest
select
host
plant
speci
influenc
select
appropri
protect
proteas
inhibitor
choic
still
made
casebycas
basi
anoth
import
biotechnolog
applic
proteas
inhibitor
protein
purif
use
ligand
affin
chromatographi
affin
chromatographi
simpl
onestep
purif
method
molecul
complex
mixtur
base
specif
high
affin
bind
ligand
immobil
solid
support
revers
proteas
inhibitor
microbi
origin
excel
ligand
purif
cognat
proteas
affin
chromatographi
depend
target
proteas
inhibitor
broad
rang
specif
inhibitori
spectrum
select
ligand
attent
must
paid
strength
inhibitor
purif
possibl
bind
weak
bind
strong
ineffect
elut
ge
advantag
use
microbi
fungal
proteas
inhibitor
mani
display
uniqu
inhibitori
profil
resist
proteolyt
cleavag
well
high
thermal
broad
ph
rang
stabil
latter
conveni
sinc
harsh
condit
may
use
immobil
matrix
well
sever
cycl
elut
step
usual
involv
extrem
chang
ph
andor
ionic
strength
broadrang
inhibitor
pepsinlik
aspart
proteas
pepstatin
use
purif
aspart
proteas
sever
differ
sourc
includ
higher
fungi
et
al
plant
payi
et
al
insect
recombin
enzym
express
bacteri
express
system
volkov
et
al
sever
differ
type
inhibitor
use
purif
serin
proteas
includ
synthet
inhibitor
benzamidin
plantand
animalderiv
proteas
inhibitor
differ
famili
polanowski
et
al
differ
inhibitori
spectra
immobil
proteas
inhibitor
use
serial
affin
chromatographi
first
broadrang
proteas
inhibitor
use
purifi
proteas
crude
protein
extract
follow
use
highli
specif
inhibitor
isol
singl
proteas
microorgan
prokaryot
domain
archaea
bacteria
kingdom
fungi
includ
higher
fungi
mushroom
constitut
import
sourc
proteas
inhibitor
microbi
proteas
inhibitor
versatil
structur
mechan
inhibit
way
differ
sourc
therefor
found
countless
applic
field
medicin
agricultur
biotechnolog
divers
process
proteas
key
player
togeth
multipl
drive
search
novel
proteas
inhibitor
could
find
applic
directli
lead
structurebas
design
number
divers
proteas
found
microorgan
rao
et
al
higher
fungi
et
al
make
virtual
inexhaust
sourc
novel
proteas
inhibitor
uniqu
featur
